S

SNN

Smith & Nephew

38.46

0.50+1.32%
Opening14:37 09/11 EDT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE38.30/37.96
TODAY RANGE38.26-38.59
VOL346.55K
MARKET CAP16.84B
52 WEEK RANGE23.30-38.79
AVG VOL (3M)967.50K
% TURNOVER0.08%
TURNOVER--
P/E (TTM)34.44
% RANGE0.87%
EPS(TTM)1.117
P/E(FORWARD)27.47
P/B3.043
BVPS12.64
DIVIDEND0.7620
P/S2.894
BETA--
DIV YIELD1.98%
FREE FLOAT MKT CAP16.84B
SHARES OUTSTANDING437.98M
NEXT EARNINGS--
FREE FLOAT437.85M
LOT SIZE1
EX-DATE10/03/2025
Same Industry
Name/Symbol
Change%
Price

S

Smith & Nephew

SNN

+1.32%
38.46

A

Atrion Corp

ATRI

0.00%
459.92

I

IDEXX Laboratories

IDXX

+0.87%
643.51

C

Cencora Inc.

COR

+1.69%
301.34

T

Teleflex Inc

TFX

+1.40%
132.12

S

Stryker Corp

SYK

+1.22%
387.65

W

West Pharm Svcs

WST

+2.44%
261.46

U

Ufp Technologies

UFPT

+1.84%
204.91

S

Shockwave Medical, Inc.

SWAV

0.00%
334.75

C

Cooper

COO

+1.11%
68.41

B

Becton Dickinson And Co

BDXB

0.00%
48.16

B

Becton Dickinson & Co

BDX

+1.01%
190.34

U

Utah Med Prods

UTMD

+0.66%
61.18

A

Align Technology Inc

ALGN

+2.22%
135.89

H

Henry Schein

HSIC

+3.03%
69.45

G

Ge Healthcare Technologies Inc

GEHC

+2.84%
78.15

R

Repligen

RGEN

-0.75%
119.33

A

Abbott Labs

ABT

+1.96%
131.90

C

Conmed Corp

CNMD

+1.58%
53.65

M

Medtronic

MDT

+1.51%
93.71

Z

Zimmer Biomet

ZBH

+1.38%
103.72
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.